Search Results - "Kudoh, Masafumi"
-
1
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts
Published in Cancer research (Chicago, Ill.) (01-09-2007)“…Various accumulating evidence suggests that survivin, a member of the inhibitor of apoptosis (IAP) family, plays an important role in drug resistance and…”
Get full text
Journal Article -
2
The selective anaplastic lymphoma receptor tyrosine kinase inhibitor ASP3026 induces tumor regression and prolongs survival in non-small cell lung cancer model mice
Published in Molecular cancer therapeutics (01-02-2014)“…Activation of anaplastic lymphoma receptor tyrosine kinase (ALK) is involved in the pathogenesis of several carcinomas, including non-small cell lung cancer…”
Get full text
Journal Article -
3
YM-359445, an Orally Bioavailable Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor, Has Highly Potent Antitumor Activity against Established Tumors
Published in Clinical cancer research (01-03-2006)“…Purpose: The vascular endothelial growth factor receptor-2 (VEGFR2) tyrosine kinase has been implicated in the pathologic angiogenesis associated with tumor…”
Get full text
Journal Article -
4
N-Arylpiperazine-1-carboxamide Derivatives: a Novel Series of Orally Active Nonsteroidal Androgen Receptor Antagonists
Published in Chemical & Pharmaceutical Bulletin (2005)“…A novel series of N-arylpiperazine-1-carboxamide derivatives was synthesized and their androgen receptor (AR) antagonist activities and in vivo antiandrogenic…”
Get full text
Journal Article -
5
A role of androgen receptor protein in cell growth of an androgen-independent prostate cancer cell line
Published in Bioscience, biotechnology, and biochemistry (01-11-2005)“…Prostate cancer, which develops due to androgen and is initially responsive to androgen deprivation therapy, often comes to acquire androgen deprivation…”
Get full text
Journal Article -
6
YM-231146, a Novel Orally Bioavailable Inhibitor of Vascular Endothelial Growth Factor Receptor-2, Is Effective against Paclitaxel Resistant Tumors
Published in Biological & Pharmaceutical Bulletin (01-11-2005)“…Chemotherapy using anticancer drugs induces serious the problem of multidrug resistance (MDR) in the cancer cells. In contrast, endothelial cells so rarely…”
Get full text
Journal Article -
7
Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target
Published in The Journal of pharmacology and experimental therapeutics (01-11-2005)“…Androgen receptor (AR) plays key roles in various biological events, including pathological processes such as prostate cancer, androgen-insensitive syndrome,…”
Get more information
Journal Article -
8
Synthesis and Pharmacological Evaluation of Novel Arylpiperazine Derivatives as Nonsteroidal Androgen Receptor Antagonists
Published in Chemical & Pharmaceutical Bulletin (01-11-2004)“…The search for novel antiandrogens by high-throughput screening (HTS) of the Yamanouchi chemical library led to the discovery of the lead compound (5), which…”
Get full text
Journal Article -
9
Studies on Aromatase Inhibitors. I. Synthesis and Biological Evaluation of 4-Amino-4H-1, 2, 4-triazole Derivatives
Published in Chemical & pharmaceutical bulletin (1996)“…Various 4-N-substituted amino-4H-1, 2, 4-triazole derivatives were synthesized and evaluated for aromatase-inhibitory activity (in vitro) and for pregnant mare…”
Get full text
Journal Article -
10
Studies on Aromatase Inhibitors. II. Synthesis and Biological Evaluation of 1-Amino-1H-1, 2, 4-triazole Derivatives
Published in Chemical & pharmaceutical bulletin (1997)“…1-N, N-Disubstituted amino-1H-1, 2, 4-triazole derivatives were prepared and evaluated for aromatase-inhibitory activity (in vitro) and for the inhibitory…”
Get full text
Journal Article -
11
Inhibitory effect of a novel non-steroidal aromatase inhibitor, YM511 on the proliferation of MCF-7 human breast cancer cell
Published in The Journal of steroid biochemistry and molecular biology (01-05-1996)“…The proliferation of MCF-7, human breast cancer cell line, was stimulated by testosterone and estradiol. The aromatase activity in MCF-7 cells, which catalysed…”
Get full text
Journal Article -
12
-
13
YM-201627: An orally active antitumor agent with selective inhibition of vascular endothelial cell proliferation
Published in Cancer letters (08-07-2006)“…We developed an oral administration-compatible, small molecular weight antitumor agent, YM-201627 by screening for the inhibition of the proliferation of…”
Get full text
Journal Article -
14
Bag1 proteins regulate growth and survival of ZR-75-1 human breast cancer cells
Published in Cancer research (Chicago, Ill.) (15-03-2002)“…Bag1 proteins bind heat shock protein M(r) 70,000 (Hsp 70) family molecular chaperones and regulate diverse pathways involved in cell proliferation, apoptosis,…”
Get full text
Journal Article -
15
(+)-(2R,5S)-4-[4-Cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an Orally Potent and Peripherally Selective Nonsteroidal Androgen Receptor Antagonist
Published in Journal of medicinal chemistry (26-01-2006)“…A novel series of trans-N-aryl-2,5-dimethylpiperazine-1-carboxamide derivatives was synthesized and their androgen receptor (AR) antagonist activities and in…”
Get full text
Journal Article -
16
YM116, 2-(1H-Imidazol-4-ylmethyl)-9H-carbazole, Decreases Adrenal Androgen Synthesis by Inhibiting C17-20 Lyase Activity in NCI-H295 Human Adrenocortical Carcinoma Cells
Published in Japanese Journal of Pharmacology (1999)“…The concentrations of androstenedione and dehydroepiandrosterone, products of C17-20 lyase, in the medium after a 6-hr incubation of NCI-H295 cells were…”
Get full text
Journal Article -
17
Stabilization of androgen receptor protein is induced by agonist, not by antagonists
Published in Biochemical and biophysical research communications (21-06-2002)“…The action of nuclear receptor ligands in target tissues is specified mainly by the expression levels of their cognate nuclear receptors. The expression levels…”
Get full text
Journal Article -
18
-
19
N-Arylpiperazine-1-carboxamide Derivatives
Published in Chemical & pharmaceutical bulletin (01-04-2005)“…A novel series of N-arylpiperazine-1-carboxamide derivatives was synthesized and their androgen receptor (AR) antagonist activities and in vivo antiandrogenic…”
Get full text
Journal Article -
20
YM116, 2-(1H-Imidazol-4-ylmethyl)-9H-carbazole, Decreases Adrenal Androgen Synthesis by Inhibiting Cl7-20 Lyase Activity in NCI-H295 Human Adrenocortical Carcinoma Cells
Published in Japanese journal of pharmacology (1999)“…The concentrations of androstenedione and dehydroepiandrosterone, products of C17-20 lyase, in the medium after a 6-hr incubation of NCI-H295 cells were…”
Get full text
Journal Article